Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_assertion description "[XRCC3 241 MetMet is an independent determinant of favorable survival in NSCLC patients treated with cisplatin/gemcitabine. A simple molecular assay to determine the XRCC3 241 genotype can be useful for customizing chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_assertion evidence source_evidence_literature NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_assertion SIO_000772 16407418 NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_assertion wasDerivedFrom gad-20130706 NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_assertion wasGeneratedBy ECO_0000203 NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.
- gad-20130706 importedOn "2013-07-06" NP64345.RA6dOpzI1qvCZP1Y6KdjKBglLkR2OUHy6gN40nZlwXpIo130_provenance.